SGLT2 Inhibitors

doi 10.36502/2020/droa.vol-1.no-s1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Asploro Open Access Publications

Related search

SGLT2 Inhibitors: Mind the Gap

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Is Cancer Incidence Modified by SGLT2 Inhibitors?

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

SGLT2 Inhibitors: Alternatives or Complementary Therapeutic Options

2020English

Class Effects of SGLT2 Inhibitors on Cardiorenal Outcomes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Sarcopenia, Frailty Circle, and Treatment With SGLT2 Inhibitors

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

SGLT2 Inhibitors for Primary Prevention of Cardiovascular Events

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Diabetes Research Open Access: Sodium Glucose Cotransporter2 (SGLT2) Inhibitors

2020English

Risk of Amputations Associated With SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Lowering the Risk of Gout: Another Benefits From Use of SGLT2 Inhibitors

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy